These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25443959)

  • 41. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
    Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A
    Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
    Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
    Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the Ser-Ser-Lys catalytic triad mechanism of peptide amidase: computational studies of the ground state, transition state, and intermediate.
    Valiña AL; Mazumder-Shivakumar D; Bruice TC
    Biochemistry; 2004 Dec; 43(50):15657-72. PubMed ID: 15595822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies.
    Pavlopoulos S; Pelekoudas DN; Benchama O; Rawlins CM; Agar JN; West JM; Malamas M; Zvonok N; Makriyannis A
    Protein Expr Purif; 2018 May; 145():108-117. PubMed ID: 29253688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.
    Vago R; Bettiga A; Salonia A; Ciuffreda P; Ottria R
    Bioorg Med Chem; 2017 Feb; 25(3):1242-1249. PubMed ID: 28062195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.
    Lodola A; Mor M; Sirirak J; Mulholland AJ
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assay of NAAA Activity.
    Tsuboi K; Ueda N
    Methods Mol Biol; 2016; 1412():137-48. PubMed ID: 27245900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
    ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling and molecular dynamics indicate that snake venom phospholipase B-like enzymes are Ntn-hydrolases.
    Coronado MA; da Silva Olivier D; Eberle RJ; do Amaral MS; Arni RK
    Toxicon; 2018 Oct; 153():106-113. PubMed ID: 30179630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.
    Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ
    J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.
    West JM; Zvonok N; Whitten KM; Wood JT; Makriyannis A
    J Proteome Res; 2012 Feb; 11(2):972-81. PubMed ID: 22040171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
    Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
    Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active
    Fotio Y; Sasso O; Ciccocioppo R; Piomelli D
    J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036
    [No Abstract]   [Full Text] [Related]  

  • 55. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory.
    Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
    Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
    Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioinformatic analysis of α/β-hydrolase fold enzymes reveals subfamily-specific positions responsible for discrimination of amidase and lipase activities.
    Suplatov DA; Besenmatter W; Svedas VK; Svendsen A
    Protein Eng Des Sel; 2012 Nov; 25(11):689-97. PubMed ID: 23043134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
    Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α-Acylamino-β-lactone
    Gagliardi A; Molinaro R; Fresta M; Duranti A; Cosco D
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453371
    [No Abstract]   [Full Text] [Related]  

  • 60. β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.
    Armirotti A; Romeo E; Ponzano S; Mengatto L; Dionisi M; Karacsonyi C; Bertozzi F; Garau G; Tarozzo G; Reggiani A; Bandiera T; Tarzia G; Mor M; Piomelli D
    ACS Med Chem Lett; 2012 May; 3(5):422-6. PubMed ID: 24900487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.